세계의 의료 공급망 시장 예측(-2032년)

According to Stratistics MRC, the Global Healthcare Supply Chain Market is accounted for $3.9 billion in 2025 and is expected to reach $9.4 billion by 2032 growing at a CAGR of 13.5% during the forecast period. Healthcare supply chain refers to the coordinated system of sourcing, producing, storing, and delivering medical products, equipment, and pharmaceuticals to healthcare providers and patients. It encompasses procurement, inventory management, logistics, and distribution, ensuring timely availability of essential supplies. This complex network involves manufacturers, distributors, hospitals, pharmacies, and regulatory bodies working together to maintain quality, reduce costs, and improve patient outcomes. With increasing digitization and demand for efficiency, modern healthcare supply chains leverage technologies like AI, IoT, and blockchain for real-time visibility and decision-making.

Market Dynamics:

Driver:

Digitization and Automation

Digitization and automation are key drivers of the market, transforming traditional logistics into intelligent, data-driven systems. Technologies like AI, IoT and blockchain enable real-time tracking and streamlined inventory management. These innovations reduce waste, improve accuracy, and enhance responsiveness across procurement and distribution networks. As healthcare providers seek greater efficiency and transparency, digital platforms are becoming essential for managing complex supply chains, ensuring timely delivery of critical supplies, and improving patient outcomes through smarter resource allocation.

Restraint:

High Implementation and Maintenance Costs

High implementation and maintenance costs pose a significant restraint to the market. Deploying advanced technologies such as AI, blockchain, and cloud-based systems requires substantial investment in infrastructure, software, and skilled personnel. Smaller healthcare facilities may struggle to afford these upgrades, limiting adoption. Ongoing maintenance, system integration, and compliance with evolving standards add further financial burden. Without scalable, cost-effective solutions, many organizations face challenges in modernizing their supply chains, potentially hindering operational efficiency and market growth.

Opportunity:

Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure presents a major opportunity for the healthcare supply chain market. Emerging economies are investing heavily in hospitals, clinics, and pharmaceutical manufacturing, driving demand for efficient supply chain systems. Improved logistics, inventory control, and procurement processes are essential to support growing patient populations and complex treatment needs. As governments and private sectors prioritize healthcare accessibility and modernization, supply chain technologies will play a critical role in ensuring timely delivery of medical products and enhancing care quality.

Threat:

Regulatory and Compliance Challenges

Regulatory and compliance challenges threaten the growth of the market. Navigating diverse regulations across regions-especially for pharmaceuticals and medical devices requires meticulous documentation, tracking, and reporting. Non-compliance can result in fines, product recalls, and reputational damage. Frequent changes in healthcare policies and data protection laws add complexity to supply chain operations. Companies must invest in robust compliance systems and stay updated with global standards to avoid disruptions and maintain trust among stakeholders in a highly regulated industry.

Covid-19 Impact:

The COVID-19 pandemic exposed vulnerabilities in global healthcare supply chains, leading to shortages of essential medical supplies and delayed deliveries. Lockdowns and transport restrictions disrupted procurement and distribution networks, prompting urgent reevaluation of supply chain resilience. In response, healthcare organizations accelerated digitization, adopted predictive analytics, and diversified sourcing strategies. The crisis highlighted the importance of real-time visibility, inventory optimization, and agile logistics. Post-pandemic, these lessons are driving long-term investments across the healthcare sector.

The big data analytics segment is expected to be the largest during the forecast period

The big data analytics segment is expected to account for the largest market share during the forecast period, due to vast volumes of healthcare data, analytics platforms enable predictive demand forecasting, inventory optimization, and risk mitigation. These tools support real-time decision-making, enhance operational efficiency, and reduce costs. As healthcare providers seek greater transparency and responsiveness, big data analytics becomes indispensable for managing complex supply chains. Its ability to uncover actionable insights drives widespread adoption across hospitals and pharmaceutical networks.

The pharmacies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmacies segment is predicted to witness the highest growth rate, due to rising demand for prescription drugs and over-the-counter products, pharmacies require efficient inventory management and streamlined procurement systems. Digital platforms enable real-time tracking, automated replenishment, and improved customer service. As retail and online pharmacies expand, supply chain optimization becomes critical to meet consumer expectations and regulatory requirements. The segment's rapid growth is fueled by increased healthcare access and focus on personalized medicine.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rapid population growth and expanding healthcare infrastructure. Countries like China, India, and Japan are investing in hospitals, pharmaceutical manufacturing, and digital health platforms. Government initiatives promoting healthcare modernization and supply chain digitization support market growth. The region's large patient base and rising demand for medical products create significant opportunities for logistics providers and technology firms, positioning Asia Pacific as a global leader in healthcare supply chain innovation.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to region's advanced healthcare systems, strong regulatory frameworks, and high adoption of digital technologies drive rapid growth. Investments in AI, blockchain, and cloud-based platforms enhance supply chain transparency, efficiency, and resilience. The U.S. and Canada are prioritizing healthcare modernization and pandemic preparedness, fueling demand for intelligent logistics solutions. With leading tech firms and healthcare providers, North America is at the forefront of supply chain transformation.

Key players in the market

Some of the key players in Healthcare Supply Chain Market include McKesson Corporation, Cardinal Health, AmerisourceBergen, Owens & Minor, Henry Schein, Medline Industries, Becton Dickinson, Thermo Fisher Scientific, DHL Supply Chain, UPS Healthcare, FedEx Corporation, IQVIA, Siemens Healthineers, SAP SE, and Oracle Corporation.

Key Developments:

In October 2025, Thermo Fisher Scientific plans to acquire Clario Holdings Inc. to enhance clinical trial capabilities for pharma and biotech clients. This strategic move aims to deliver deeper clinical insights, streamline data collection, and accelerate innovation in drug development and patient care.

In July 2025, Thermo Fisher and Sanofi have expanded their strategic partnership to enhance U.S.-based drug manufacturing. This collaboration focuses on leveraging Thermo Fisher's biologics capabilities to support Sanofi's pipeline, ensuring faster, more reliable production of innovative therapies for patients across North America.

Components Covered:

• Software
• Hardware
• Services

Functions Covered:

• Sourcing and Procurement
• Inventory Management
• Order Management
• Logistics and Distribution
• Demand Forecasting and Planning
• Manufacturing and Production Management
• Other Functions

Deployment Modes Covered:

• On-Premise
• Cloud-Based
• Web-Based

Technologies Covered:

• Artificial Intelligence (AI)
• Internet of Things (IoT)
• Blockchain
• Big Data Analytics
• Cloud Computing
• RFID and Barcode Systems

End Users Covered:

• Manufacturers
• Distributors
• Healthcare Providers
• Pharmacies
• Logistics Companies
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Technology Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Healthcare Supply Chain Market, By Component

• 5.1 Introduction
• 5.2 Software
• 5.3 Hardware
• 5.4 Services

6 Global Healthcare Supply Chain Market, By Function

• 6.1 Introduction
• 6.2 Sourcing and Procurement
• 6.3 Inventory Management
• 6.4 Order Management
• 6.5 Logistics and Distribution
• 6.6 Demand Forecasting and Planning
• 6.7 Manufacturing and Production Management
• 6.8 Other Functions

7 Global Healthcare Supply Chain Market, By Deployment Mode

• 7.1 Introduction
• 7.2 On-Premise
• 7.3 Cloud-Based
• 7.4 Web-Based

8 Global Healthcare Supply Chain Market, By Technology

• 8.1 Introduction
• 8.2 Artificial Intelligence (AI)
• 8.3 Internet of Things (IoT)
• 8.4 Blockchain
• 8.5 Big Data Analytics
• 8.6 Cloud Computing
• 8.7 RFID and Barcode Systems

9 Global Healthcare Supply Chain Market, By End User

• 9.1 Introduction
• 9.2 Manufacturers
• 9.3 Distributors
• 9.4 Healthcare Providers
• 9.5 Pharmacies
• 9.6 Logistics Companies
• 9.7 Other End Users

10 Global Healthcare Supply Chain Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 McKesson Corporation
• 12.2 Cardinal Health
• 12.3 AmerisourceBergen
• 12.4 Owens & Minor
• 12.5 Henry Schein
• 12.6 Medline Industries
• 12.7 Becton Dickinson
• 12.8 Thermo Fisher Scientific
• 12.9 DHL Supply Chain
• 12.10 UPS Healthcare
• 12.11 FedEx Corporation
• 12.12 IQVIA
• 12.13 Siemens Healthineers
• 12.14 SAP SE
• 12.15 Oracle Corporation